Cypriot facility that will be distributing premium EU-GMP medicinal cannabis produce
CyCann Pharmaceuticals was born from the joint vision of a management team combining their existing expertise in medicinal cannabis cultivation at scale, the founders had a passion and a focus for their homeland in Cyprus and becoming the first to produce a much needed Cypriot medicinal cannabis product in partnership with the University of Cyprus.
Who is CyCann Pharmaceuticals?
CyCann Pharmaceuticals was established to become the first Cypriot medicinal cannabis producer after tenders are issued in 2025, our goal is to be the largest European producer of effective European Union Good Manufacturing Practice (EU-GMP) certified medicinal cannabis, to the global markets.
We will establish a medicinal cannabis centre of excellence in Cyprus, with strong links via a University of Cyprus research partnership and pharmaceutical company collaborations. We will know we’ve accomplished that goal when we deliver our first products to market through drug discovery and clinical trial programmes providing novel and proprietary medicinal cannabis products that become licensed for patients within the EU and Cyprus.
Key Highlights
CyCann Pharmaceuticals will supply EU-GMP medicinal cannabis THC flower and THC extracts to qualified and licensed European cannabis establishments in the pharmaceutical industry.
Job Creation
State-of-the-art Facility
Certification
Monthly Production Yield
Products
EU Distribution
Expert Advisory Board
Offtake
Main Objectives
To become one of the leading producers in Cyprus of the highest quality medicinal cannabis for the European market, offering diverse strain selection through genetic research.
- High-quality EU-GMP certified, consistent product
- Monthly sales and capacity increasing steadily throughout the first operational year
- Low production cost per gram
- Net annual income to support operational expenses
- High yield with low product and facility contamination risk
License Application 2025
3 licenses will be issued in Cyprus, CyCann has assembled an expert management team with experience scaling cannabis cultivation operations.
Operations
Establish the main business functions, recruit expert team and advisory panel, shortlisting and establishing land sites
Media Relations
Partnership with Red Wolf, PR & Marketing agency, to support CyCann’s PR, public affairs & corporate communications.
Partnering
A research and development partnership has been agreed with University of Cyprus to conduct in vitro and in vivo research.